Microbeam Radiation for Selective Tumor Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments, particularly for inoperable or multiple small tumors in the brain and lung, face challenges in selectively targeting tumor tissue while minimizing damage to healthy tissue, as conventional radiotherapy is non-selective and requires high radiation doses, and existing combinations of chemotherapy and radiotherapy have shown limited synergistic effects.
Innovation Solution
A preparation involving a therapeutically active, non-cytotoxic dose of microbeam radiation is administered to create microscopic damage regions in tumor tissue boundary walls, followed by the administration of chemotherapeutic or cytotoxic substances to enhance permeability and allow easier diffusion into the tissue, using a combination of synchrotron radiation and specific drug substances like platinum-containing agents or noble metal nanoparticles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional radiotherapy is used to treat inoperable or multiple small tumors, then tumor growth can be suppressed, but healthy tissue suffers excessive damage due to non-selective radiation delivery
Solution Approach 1:
The radiation beam is segmented into multiple discrete beams that are delivered from different angles and directions. Each beam targets a specific tumor region, and the segmentation allows healthy tissue to be exposed to radiation from multiple directions rather than a single high-dose direction, reducing concentrated damage to any one healthy tissue area.
Solution Approach 2:
The radiation dose distribution is optimized to provide high dose to tumor tissue while limiting dose to surrounding healthy tissue. The treatment plan uses three-dimensional conformal radiotherapy techniques to shape the radiation dose to match the tumor geometry, ensuring local quality improvement in tumor control while protecting adjacent healthy structures.
2Reliability
If high radiation doses are administered to ensure tumor control, then tumor growth suppression improves, but the risk of damaging healthy tissue increases
Solution Approach 1:
The total radiation dose is divided into multiple fractions delivered over time, with each fraction consisting of multiple discrete beams. This segmentation allows the tumor to accumulate a high total dose while healthy tissue receives distributed, lower-dose exposure that allows for repair between fractions.
Solution Approach 2:
Radiation is delivered in periodic fractions rather than a single continuous exposure. The treatment schedule includes intervals between fractions that allow healthy tissue to repair sublethal damage while the tumor, having poorer repair capacity, accumulates lethal damage over the course of treatment.
3Reliability
If chemotherapy is combined with radiotherapy to enhance tumor killing, then treatment effectiveness improves, but selectivity between tumor and healthy tissue remains limited
Solution Approach 1:
The treatment combines segmented radiation delivery with chemotherapy timing optimization. Radiation beams are delivered in specific sequences with chemotherapy administration timed to coincide with periods when tumor cells are most radiosensitive, enhancing tumor kill while allowing healthy tissue to recover between treatment modalities.
Solution Approach 2:
Chemotherapy is administered at strategically timed intervals before radiation fractions to sensitize tumor cells to radiation. This preliminary chemical action enhances the subsequent radiation effect on tumor cells while the healthy tissue, having better repair mechanisms, can recover from the combined exposure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves a synergistic effect with lower radiation doses, increasing the selectivity and effectiveness of tumor treatment by improving drug delivery through transiently damaged vascular walls, reducing tumor size without lethal effects on healthy tissue, and offering a more targeted and less invasive treatment option.
Implementation Method 1
highly energetic deceleration radiation (so-called Bremsstrahlung) of charged particles (e.g. electrons, ions) in the form of synchrotron radiation
Implementation Method 2
highly energetic deceleration radiation (so-called Bremsstrahlung) of charged particles
Implementation Method 3
allow easier diffusion into the tissue
Data Source
Figure 1a~1b
Figure 2a~2b
Figure 3a~3e
AI summary
The present invention provides a substance comprising a preparation of at least one chemotherapeutic or cytotoxic substance for the use in treatment of a disease of a mammalian patient, especially in the treatment of cancer. The invention suggests a symbiotic or synergistic combination of radiotherapy and chemotherapeutic or cytotoxic drug delivery.